文献速递免疫规划卫生政策与健康促进

各国是否应改用五剂或十剂轮状病毒疫苗?

Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
PubMed 文献 · Vaccine · 2021-06-19

研究利用HERMES模拟模型评估贝宁、莫桑比克和印度比哈尔邦疫苗供应链中九种轮状病毒疫苗 presentations 的运营与经济影响,发现五剂或十剂疫苗相比单剂或两剂疫苗能持续减少冷链约束并提高轮状病毒疫苗和总疫苗可用性。

要点

  • 五剂轮状病毒疫苗较单剂和两剂疫苗提高轮状病毒疫苗可用性(52-92%)和总疫苗可用性(60-85%)。
  • 十剂疫苗在贝宁和比哈尔邦实现最高的轮状病毒疫苗可用性。
  • 单剂疫苗中Rotarix RV1 MMP的可用性最高(49-80%),总疫苗可用性56-79%。

核心结论

  • 使用五剂或十剂轮状病毒疫苗的国家能持续减少冷链约束,并实现比单剂或两剂疫苗更高的轮状病毒疫苗和总疫苗可用性。

研究设计与样本

  • 研究使用HERMES生成的模拟模型,模拟贝宁共和国、莫桑比克和印度比哈尔邦的疫苗供应链,评估九种不同轮状病毒疫苗 presentations 的运营和经济影响。

主要发现

  • 在单剂轮状病毒疫苗中,使用Rotarix RV1 MMP导致最高的轮状病毒疫苗可用性(49-80%)和总疫苗可用性(56-79%),并降低每剂接种总成本($0.02-$0.10)。
  • 使用两剂ROTASIIL compared to Rotarix RV1 MMP(最小的单剂疫苗)在每个供应链中使轮状病毒疫苗可用性降低3-6%。
  • 使用五剂轮状病毒疫苗相比单剂和两剂疫苗提高轮状病毒疫苗可用性(52-92%)和总疫苗可用性(60-85%)。
  • 使用十剂疫苗在贝宁和比哈尔邦均实现所有轮状病毒疫苗中最高的轮状病毒疫苗可用性。

临床怎么用

  • 各国在选择轮状病毒疫苗时,可考虑采用五剂或十剂 presentation 以缓解冷链约束并提高疫苗可用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Single-dose rotavirus vaccines, which are used by a majority of countries, are some of the largest-sized vaccines in immunization programs, and have been shown to constrain supply chains and cause bottlenecks. Efforts have been made to reduce the size of the single-dose vaccines; however, with two-dose, five-dose and ten-dose options available, the question then is whether using multi-dose instead of single-dose rotavirus vaccines will improve vaccine availability. METHODS: We used HERMES-generated simulation models of the vaccine supply chains of the Republic of Benin, Mozambique, and Bihar, a state in India, to evaluate the operational and economic impact of implementing each of the nine different rotavirus vaccine presentations. RESULTS: Among single-dose rotavirus vaccines, using Rotarix RV1 MMP (multi-monodose presentation) led to the highest rotavirus vaccine availability (49-80%) and total vaccine availability (56-79%), and decreased total costs per dose administered ($0.02-$0.10) compared to using any other single-dose rotavirus vaccine. Using two-dose ROTASIIL decreased rotavirus vaccine availability by 3-6% across each supply chain compared to Rotarix RV1 MMP, the smallest single-dose vaccine. Using a five-dose rotavirus vaccine improved rotavirus vaccine availability (52-92%) and total vaccine availability (60-85%) compared to single-dose and two-dose vaccines. Further, using the ten-dose vaccine led to the highest rotavirus vaccine availability compared to all other rotavirus vaccines in both Benin and Bihar. CONCLUSION: Our results show that countries that implement five-dose or ten-dose rotavirus vaccines consistently reduce cold chain constraints and achieve higher rotavirus and total vaccine availability compared to using either single-dose or two-dose rotavirus vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wedlock PT, Cox SN, Bartsch SM, et al. Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available? Vaccine. 2021. PMID: 34158215. doi:10.1016/j.vaccine.2021.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。